Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 72INDUSTRY 10OTHER_GOV 3NIH 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Breast 1

Conditions

Cancer Pain 2Wounds and Injuries 1Head and Neck Neoplasms 1Breast Neoplasms 1Breakthrough Pain 1Agnosia 1

Interventions

Cisplatin 48Capecitabine 41Gemcitabine 33apatinib 32Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Nivolumab 17pembrolizumab 16Surgical Procedures, Operative 16Exercise 16Metformin 15S 1 (combination) 14camrelizumab 13Radiation 13Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11Vinorelbine 10Standard of Care 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Morphine × Clear all
NCT05800834 2023-09-28

MorphineGEL

Instituto Nacional de Cancer, Brazil

Phase 2 Unknown
106 enrolled
BreastHead & Neck

Cancer Pain, Breast Neoplasms, Head and Neck Neoplasms, Wounds and Injuries

NCT05037539 2022-08-31

Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain

Department of Medical Services Ministry of Public Health of Thailand

Phase 1/2 Completed
20 enrolled

Breakthrough Pain

NCT04243954 2021-03-05

Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration

Fujian Cancer Hospital

Phase 2 Completed
95 enrolled

Cancer Pain, Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡